首页> 外国专利> METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY

METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY

机译:评估孤立型口腔龋病患者的临床疗效的方法

摘要

FIELD: medicine.;SUBSTANCE: method of assessing the clinical effectiveness in the patients with the isolated form of acantholytic pemphigus comprises oral fluid examination, wherein on 14th day of treatment, the concentration of interleukin-4 (IL-4), interleukin-6 (IL-6) and interleukin-1β (IL-1β) and with IL-4 values 46 pg/ml and higher, IL-6 1.5 pg/ml and below, IL-1β 85 pg/ml and lower treatment efficiency is assessed as low, and with IL-4 values 43 pg/ml and lower, IL-6 2.0 pg/ml and higher, IL-1β 89.0 pg/ml and higher clinical effectiveness is considered to be high.;EFFECT: invention refers to dermatology, dentistry and clinical laboratory diagnostics.;1 cl, 2 ex
机译:领域:药物:评估分离棘皮天疱疮患者临床疗效的方法包括口服液检查,其中在治疗的第14天,白细胞介素4(IL-4),白细胞介素6的浓度(IL-6)和白介素-1β(IL-1β),且IL-4值为46 pg / ml和更高,IL-6 1.5 pg / ml和更低,IL-1β85 pg / ml且治疗效率较低低,且IL-4值为43 pg / ml和更低,IL-6 2.0 pg / ml和更高,IL-1β89.0 pg / ml和更高的临床有效性被认为是高的。效果:本发明涉及皮肤病学,牙科和临床实验室诊断。; 1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号